Results 1 to 10 of about 28,082 (192)

Acceptability of misoprostol-only medication abortion dispensed by mail-order or retail pharmacy: a qualitative study based on in-depth interviews in the United States [PDF]

Sexual and Reproductive Health Matters
The WHO recommends two medication abortion regimens, either misoprostol used with mifepristone or misoprostol-only. Both regimens are recognised as safe and effective, but in the United States (US) most abortions are completed using mifepristone and ...
Dana M. Johnson, Sruthi Ramaswamy, Rebecca Gomperts   +2 more
doaj   +2 more sources

Evaluation of Low-dose and High-dose Intravaginal Misoprostol for Induction of Labour: A Randomised, Double-blinded, Single Centre Study [PDF]

Journal of Clinical and Diagnostic Research, 2022
Introduction: Misoprostol is a synthetic prostaglandin E1 analogue widely used for cervical ripening and labour induction. However, optimal dose of misoprostol required to induce labour is still controversial.
Gowthami Mummalaneni, Thodeti Chaitanya Sravanthi, I Sridhar, Suresh Babu Sayana, Meela Ranjith Kumar   +4 more
doaj   +1 more source

Potency and acceptability of oral misoprostol compared with vaginal misoprostol prior to first trimester abortion [PDF]

New Indian Journal of OBGYN, 2020
Objectives: Present study was done to assess the effectiveness and acceptability of oral misoprostol compared with vaginal misoprostol for cervical priming before termination of first trimester pregnancy.
Varsha Kotwal
doaj   +1 more source

The difference of Bishop score change and labor event between oral and vaginal misoprostol in pregnancy beyond 41 weeks

Majalah Obstetri dan Ginekologi, 2023
HIGHLIGHTS • Oral misoprostol is more effective than vaginal misoprostol in cervical ripening as a part of induction of labor. • Oral misoprostol is as safe as vaginal misoprostol.   ABSTRACT Objective: To compare Bishop score changes and labor
Maskasoni Maskasoni, Julian Dewantiningrum   +1 more
doaj   +1 more source

Comparative Study of Oral and Vaginal Misoprostol for Induction of Labour, Maternal and Foetal Outcome [PDF]

Journal of Clinical and Diagnostic Research, 2013
Background: Misoprostol is a new promising agent for cervical ripening and induction of labour .The ideal dose, route and frequency of administration of misoprostol are still under investigation.
Kambhampati Komala, Meherlatha Reddy, Iqbal Jehan Quadri, Suneetha B., Ramya V.   +4 more
doaj   +1 more source

A prospective study on the effectiveness of a combination regime (Mifepristone and Misoprostol) in comparison with Misoprostol for missed abortion

Journal of Family Medicine and Primary Care, 2023
Introduction: Misoprostol is widely used in the medical management of missed abortions. However, pretreatment with Mifepristone has shown to be effective but still not recommended to be used in missed abortions.
Nidhi Gupta, Reva Tripathi, Sumedha Sharma, Aruna Nigam, Sanjeet Panesar   +4 more
doaj   +1 more source

Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic review

BMC Women's Health, 2020
Background A wide range of drugs have been studied for first trimester medical abortion. Studies evaluating different regimens, including combination mifepristone and misoprostol and misoprostol alone regimens, show varying results related to safety ...
Ferid A. Abubeker, Antonella Lavelanet, Maria I. Rodriguez, Caron Kim   +3 more
doaj   +1 more source

PERBANDINGAN EFEKTIVITAS MISOPROSTOL DOSIS 50 µg DAN 100 µg TERHADAP KEBERHASILAN KELAHIRAN INDUKSI DI RSU PKU MUHAMMADIYAH YOGYAKARTA

Pharmaciana, 2014
In recent years, misoprostol that is a prostaglandin E1 analogue has been used in cervix ripening at pregnancy and labor induction. However, until now misoprostol dosage and administration route for induction are various.
Haafizah Dania , Djoko Wahyono, Sulistiari Retnowati   +2 more
doaj   +1 more source

A double-blind randomized controlled trial of two different doses of misoprostol for cervical priming prior to office hysteroscopy

Middle East Fertility Society Journal, 2015
Objective: To evaluate and compare the effectiveness of 200 μg vaginal misoprostol vs. 400 μg vaginal misoprostol administrated 3 h prior to office hysteroscopy, in cervical priming. Design: Randomized controlled trial.
Waleed El-Khayat, Login Dwidar, Heba Elsawah, Omima Idris   +3 more
doaj   +1 more source

Exacerbation of celecoxib-induced renal injury by concomitant administration of misoprostol in rats.

PLoS ONE, 2014
Nonsteroidal anti-inflammatory drugs (NSAIDs) can produce adverse effects by inhibiting prostaglandin (PG) synthesis. A PGE1 analogue, misoprostol, is often utilized to alleviate NSAID-related gastrointestinal side effects. This study examined the effect
Dustin L Cooper, Derek E Murrell, Christopher M Conder, Victoria E Palau, Grace E Campbell, Shaun P Lynch, James W Denham, Angela V Hanley, Kenny W Bullins, Peter C Panus, Krishna Singh, Sam Harirforoosh   +11 more
doaj   +1 more source